13F-HR filed by Healthcare Value Capital, LLC
Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 30 holding rows worth $68,074,000.
- Accession
- 0000919574-16-013178
- Filer
- CIK 1458461
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 30 entries on the cover page, a total value of $68,074,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $68,078,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 395,000 | $13,296,000 | thousands by filing date | |
| ALBANY MOLECULAR RESH | 012423109 | COMMON STOCK | 402,400 | $6,153,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 175,000 | $5,187,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 25,000 | $5,138,000 | thousands by filing date | put |
| DEPOMED INC | 249908104 | COM | 350,000 | $4,876,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 66,208 | $4,731,000 | thousands by filing date | |
| ARTIVION INC | 228903100 | COM | 400,000 | $4,300,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 2,157,200 | $4,293,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 10,000 | $2,681,000 | thousands by filing date | |
| PROSHARES TR ULTSH NASD BIOT | 74347B789 | CEF | 50,000 | $2,178,000 | thousands by filing date | call |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 50,000 | $2,028,000 | thousands by filing date | call |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 50,000 | $2,025,000 | thousands by filing date | call |
| PROSHARES TR | 74348A319 | ULTSHT RUSS2000 | 50,000 | $1,939,000 | thousands by filing date | call |
| DEPOMED INC | 249908104 | COM | 100,000 | $1,393,000 | thousands by filing date | call |
| PROSHARES TR | 74348A319 | ULTSHT RUSS2000 | 25,000 | $969,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 50,000 | $897,000 | thousands by filing date | call |
| ALBANY MOLECULAR RESH | 012423109 | COMMON STOCK | 50,000 | $765,000 | thousands by filing date | call |
| CYTOKINETICS INC | 23282W605 | COM NEW | 100,000 | $705,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 175,000 | $621,000 | thousands by filing date | call |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 50,000 | $609,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 20,000 | $559,000 | thousands by filing date | put |
| ARTIVION INC | 228903100 | COM | 50,000 | $538,000 | thousands by filing date | call |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 35,000 | $426,000 | thousands by filing date | call |
| FIBROCELL SCIENCE INC | 315721209 | COM NEW | 147,769 | $369,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 100,000 | $355,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 31,850 | $294,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 50,000 | $269,000 | thousands by filing date | |
| APRICUS BIOSCIENCES INC | 03832V109 | COM | 440,000 | $256,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 100,000 | $147,000 | thousands by filing date | call |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 150,000 | $81,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-16-013178 | this filing | 2016-05-16 | acceptance time not in the bulk data set |